- Entry
- $131.59
- Final
- $152.05 +15.5%
- Target
- —
- Score
- +1.00
TWEEDLE TIMES—The biotech boom appears to be well underway after a three-year sabbatical. Biotech has been out of favor since its massive crash in June 2022, when investors like Cathie Wood lost as much as 90% in the sector. Wood returned to the space this week with a $13.9 million bet on high-stakes/gene-editing biotech company, Beam Therapeutics (BEAM). The IBB iShares Biotechnology ETF shows promise as a clear uptrend is now visible. But the rally could meet headwinds due to …
— ORIGINAL POST ·
Biotech Stocks Set for Bull-Market Boom✅
· r/CountryDumb
· Jul 11, 2025